Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab
- PMID: 19373893
- DOI: 10.1002/ajh.21415
Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
